Pfizer Takes On Gilead, Novartis With New Deal In Cancer Drugs – Investor’s Business Daily
|
Pfizer Takes On Gilead, Novartis With New Deal In Cancer Drugs
Investor’s Business Daily CAR–T therapies from Gilead and Novartis already are on the market. These drugs are created using a patient's own extracted immune cells. Scientists reprogram a patient's cells to fight cancer before returning them to the patient. Pfizer and Allogene … |
